Bio Farma Partners with IsDB to Strengthen Vaccine Production in Africa
PT Bio Farma, a state-owned vaccine and pharmaceutical company in Indonesia, has partnered with the Islamic Development Bank (IsDB) to strengthen vaccine production capabilities and capacity in Africa. The agreement was signed on September 3, 2024, at the Bali Nusa Dua Convention Center during the Indonesia-Africa Forum (IAF).
This partnership is part of Bio Farma's Reverse Linkage Program, which aims to facilitate the exchange of knowledge and technology among IsDB member countries and Muslim communities in non-member countries. Through this program, Bio Farma will collaborate with the Institut Pasteur de Dakar (IPD) in Senegal to support the African Union's target of achieving 60% vaccine resilience by 2040.
The collaboration will focus on improving vaccine production capabilities and capacity in Africa, with a particular emphasis on enhancing global health and vaccine resilience. The African vaccine market is projected to reach US$5 billion, and this partnership will play a crucial role in ensuring access to affordable and quality vaccines for the African population.
Bio Farma's finance and risk management director, IGN Suharta Wijaya, highlighted the importance of private sector engagement in assisting vaccine production in Indonesia. He emphasized that by expanding the Reverse Linkage Program, Bio Farma is not only committed to supporting vaccine resilience in Africa but also to expanding its commercial activities globally.
This partnership is a significant step towards achieving vaccine self-sufficiency in Africa and improving global health outcomes. By leveraging the expertise and resources of Bio Farma and IsDB, the collaboration will contribute to strengthening healthcare systems and ensuring equitable access to vaccines for all.
5 Comments
Fuerza
The partnership highlights the importance of private sector engagement in public health initiatives, demonstrating the potential for collaboration between governments and businesses.
Manolo Noriega
The collaboration can address intellectual property rights and promote affordable access to vaccines by focusing on technology transfer and local production capabilities.
Fuerza
The text lacks details about the specific expertise and resources Bio Farma will bring to the table. More information is needed for proper evaluation.
Pinochet
Focusing on the Institut Pasteur de Dakar allows for targeted support and capacity building in a leading research institution in Africa, potentially having a broader impact.
Manolo Noriega
By ensuring transparency and equitable distribution of benefits, the partnership can contribute to sustainable development and address concerns about inclusivity.